Grace Therapeutics's market cap is currently $42.73M. The company's EPS TTM is $-0.21; its P/E ratio is ―; Grace Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
